BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Newcastle Hospitals Clinical Skills Academy - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://skillsacademy.newcastle-hospitals.nhs.uk
X-WR-CALDESC:Events for Newcastle Hospitals Clinical Skills Academy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241003T093000
DTEND;TZID=Europe/London:20241003T123000
DTSTAMP:20250429T144244Z
CREATED:20240614T100835Z
LAST-MODIFIED:20250429T144244Z
UID:10000081-1727947800-1727958600@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Novel Immunotherapies for Solid Tumours - October 2024
DESCRIPTION:Please note that this course has been moved to Wednesday 27th November 2024\, please follow Novel Immunotherapies for Solid Tumours – November 2024\n  \nAn introduction to progress made in developing novel immunotherapies for solid tumours (excluding immune checkpoint inhibitors). \nOverview\nThis course emphasises the progress made in developing novel immunotherapies for solid tumours\, such as CAR T cell therapy\, TCR-engineered T cell therapy\, tumour infiltrating lymphocytes\, T cell engagers\, and vaccine-based treatments. \nOver the course of one morning\, Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – discusses novel approaches that may have a future as standard treatments for solid tumours including features of solid tumours that provoke the immune system and those that allow cancer cells to survive and thrive. \nElaine will describe cancers where novel immunotherapies are being most intensively explored\, such as in the treatment of: \n\ncancers already known to be sensitive to immunotherapy\, such as melanoma skin cancer\ncancers where new treatments are desperately needed\, such as pancreatic cancer and glioblastoma\ncancers where a particularly promising target has been identified\, such as Claudin 18.2 in stomach cancer and other GI cancers.\n\nIn the second session of the morning\, Elaine focuses on cell-based immunotherapies such as TIL (tumour infiltrating lymphocyte) therapy\, CAR T cell therapy\, and TCR-engineered T cell therapy. She explains why we haven’t made more progress with these treatments and explores how this might change in the future. \nIn the final session\, Elaine will examine some of the most innovative and exciting immunotherapies being developed\, including T cell engagers and mRNA vaccines. \nAudience\nThis content is ideal for research nurses\, clinical nurse specialists\, pharmacists\, and clinical trials coordinators. It may also interest other healthcare professionals wanting to improve their understanding of immunotherapy. \nAttendance on Elaine’s other course: A Beginner’s Guide to Cancer Immunotherapy would be ideal preparation for this course. \nAs ever\, Elaine will use colourful illustrations and jargon-free explanations to help learners gain a broad understanding of the concepts covered. \nCourse delivery\nThe course is delivered online via Microsoft Teams as follows: \n9.30am – Introduction to novel immunotherapies for solid tumours \n\nThe cancer-immunity cycle\nWhy not every cancer is sensitive to immunotherapy; exploring ‘Hot’\, ‘Cold’\, ‘Immune-suppressed’ and ‘Immune-excluded’ cancers\nHow cancer’s relationship with the immune system differs in different cancer types and the mechanisms that drive this\nIntroducing the cancers in which novel immunotherapies are being explored\n\nQ&A/break \n10.30am – Progress in cell-based immunotherapy for solid tumours \n\nWhere it started: TIL (tumour infiltrating lymphocyte) therapy\nIntroduction to CAR T cell therapy\nCAR proteins and their targets\nWhy don’t we have CAR T cell therapies for solid tumours?\nAn alternative approach: TCR-engineered T cells\n\nQ&A/break \n11.30am – Treatment vaccines\, T cell engagers and other novel approaches in trials \n\nVaccine-based immunotherapy – the general idea and the multitude of approaches being investigated\nPromising results from mRNA vaccine trials\nTebentafusp and tarlatamab – the first T cell engagers approved for solid tumours\nImmunotherapies that leverage macrophages and NK cells\n\nQ&A \n12.30pm – close \nCourse lead\nDr Elaine Vickers PhD of Science Communicated Ltd\nDr Elaine Vickers\, PhD of Science Communicated Ltd has worked as a cancer educator for over twenty years and has previously acted as science communicator for three of the UK’s leading medical research charities\, including four years in the Science Information team at Cancer Research UK. \nElaine is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies and immunotherapies. \nShe is experienced in teaching people with any level of scientific or medical knowledge from cancer patients through to medical oncologists translating complex and often overwhelming topics into easily digestible and understandable knowledge\, using colourful illustrations to explain scientific concepts. \nThe second edition of her book\, A Beginner’s Guide to Targeted Cancer Treatments – commended by the British Medical Association book awards – is due out by the end of 2024. \nBooking\nTo book a place on this course go to Tickets at the bottom of the page. \nAt checkout you can make an online card payment or enter a coupon code to make alternative payment arrangements. \nAlternative payment arrangements include: \n\nrequesting an invoice (INVOICE)\,\nThe Newcastle upon Tyne Hospitals NHS Foundation Trust staff internal funding (NUTH) – you will need to complete a Trust study leave form.\n\nPlease see the Making payments & Coupons sections of the Help and FAQs.
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/novel-immunotherapies-for-solid-tumours-october-2024/
LOCATION:Virtual delivery via MS Teams
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2023/10/MicrosoftTeams-image.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241022T093000
DTEND;TZID=Europe/London:20241022T123000
DTSTAMP:20250429T143126Z
CREATED:20240614T130156Z
LAST-MODIFIED:20250429T143126Z
UID:10000080-1729589400-1729600200@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Beginner's Guide to Cancer Immunotherapy - October 2024
DESCRIPTION:This course will introduce the science behind many forms of immunotherapy\, including immune checkpoint inhibitors\, treatment vaccines\, and CAR T cells. \nOverview\nAn introduction to immunotherapy: what it is\, how it works\, and who it’s given to. \nDuring this half day course Dr Elaine Vickers – a leading independent educator on the science of new cancer treatments – will introduce the science behind modern cancer immunotherapies for solid tumours and haematological cancers. \nThe course begins with an introduction to the relationship between cancer and the immune system. This relationship evolves with time\, and Elaine will describe how cancer cells evade and suppress white blood cells to stay alive. \nShe then explains how immune checkpoint inhibitors such as nivolumab and pembrolizumab hope to boost the cancer-fighting response from the person’s immune system. To do this\, she’ll discuss some of the critical features of T lymphocytes and why they’re the focus of these treatments. \nFinally\, in the third session of the morning\, Elaine will describe many other forms of immunotherapy given to cancer patients. These include treatment vaccines\, oncolytic viruses\, double-ended proteins called T cell engagers\, TIL (tumour-infiltrating lymphocyte) therapy\, and CAR T cells. She’ll explain briefly how they work and why they’re valuable treatments for some patients and not others. \nAudience\nThis content is ideal for research nurses\, clinical nurse specialists\, pharmacists\, and clinical trials coordinators. It may also interest other healthcare professionals wanting to improve their understanding of immunotherapy. \nThis course is ideal for anyone new to cancer immunotherapy and would like to understand how these treatments came about and how they work. \nAs ever\, Elaine will use colourful illustrations and jargon-free explanations to help learners gain a broad understanding of the concepts covered. \nCourse delivery\nThe course comprises a single morning comprising three sessions\, delivered online via Microsoft Teams\, focusing on the following: \n\nSession one: An introduction to cancer and the immune system\nSession two: Immune checkpoint inhibitors\nSession three: Other forms of immunotherapy\n\nDetailed Programme\n9:30am Session 1 – Cancer’s relationship with the immune system  \n•         A brief introduction to the human immune system \n•         How our cells talk to our immune system \n•         Our immune system’s role in protecting us from cancer \n•         How cancer’s relationship with the immune system changes over time \n•         The difference between “cancer friends” and “cancer foes” \n10:30am Session 2 – Immunotherapy with checkpoint inhibitors  \n•         An introduction to T lymphocytes (T cells) \n•         What T cells do and why our body needs to control them \n•         How T cells kill cancer cells and what sometimes stops them \n•         The mechanism of action of immune checkpoint inhibitors such as pembrolizumab\, nivolumab\, and ipilimumab \n11:30am Session 3 – Other forms of immunotherapy  \n•         An overview of different immunotherapy strategies\, such as: \n•         Antibody-based immunotherapies given to people with haematological cancer \n•         T cell engagers: double-ended proteins that connect cancer cells and T cells \n•         Vaccine-based treatments that alert the body to the presence of cancer cells \n•         Using living T cells to treat cancer \n12.30pm – close \nCourse lead\nDr Elaine Vickers PhD of Science Communicated Ltd\nDr Elaine Vickers\, PhD of Science Communicated Ltd has worked as a cancer educator for over twenty years and has previously acted as science communicator for three of the UK’s leading medical research charities\, including four years in the Science Information team at Cancer Research UK. \nElaine is passionate about demystifying the science behind cancer biology and the latest cancer treatments such as kinase inhibitors\, monoclonal antibodies and immunotherapies. \nShe is experienced in teaching people with any level of scientific or medical knowledge from cancer patients through to medical oncologists translating complex and often overwhelming topics into easily digestible and understandable knowledge\, using colourful illustrations to explain scientific concepts. \nThe second edition of her book\, A Beginner’s Guide to Targeted Cancer Treatments – commended by the British Medical Association book awards is due out by the end of 2024. \nBooking\nTo book a place on this course go to Tickets at the bottom of the page. \nAt checkout you can make an online card payment or enter a coupon code to make alternative payment arrangements. \nAlternative payment arrangements include: \n\nrequesting an invoice (INVOICE)\,\nThe Newcastle upon Tyne Hospitals NHS Foundation Trust staff internal funding (NUTH) – you will need to complete a Trust study leave form.\n\nPlease see the Making payments & Coupons sections of the Help and FAQs.
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/beginners-guide-to-cancer-immunotherapy-october-2024/
LOCATION:Virtual delivery via MS Teams
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2023/10/MicrosoftTeams-image-1.jpg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241031T090000
DTEND;TZID=Europe/London:20241031T170000
DTSTAMP:20250429T145049Z
CREATED:20240614T131716Z
LAST-MODIFIED:20250429T145049Z
UID:10000083-1730365200-1730394000@skillsacademy.newcastle-hospitals.nhs.uk
SUMMARY:Trauma & Orthopaedic Surgical Trainee Casting Course - October 2024
DESCRIPTION:During this two day course delegates will learn the basic casting techniques and skills specifically required for trauma and orthopaedic settings within the NHS.  \nOverview\nThis course explore the appropriate prescription relating to injury including the safe application of backslabs as well as full casts with manipulation techniques. \nDelivery of the course comprises a range presentations and workshop learning led by specialists in their field: \n\nMr Dan Hipps\, Trauma and Orthopaedics\nMr Phil Dobson\, Trauma and Orthopaedics (Consultant)\nPaul Maher\, Senior Orthopaedic Practitioner\nDani Hodgson\, Orthopaedic Practitioner\n\nThe hybrid theoretical and practice approach includes regular Q&A sessions\, assessment and periods of reflection\, all designed to support delegates to understand and consider: \n\na summary of the professional accountability and legal issues associated with cast application;\nthe theoretical basic to justify the decision making process in the selection of the appropriate casting technique\, focusing on prescription\, materials\, positioning\, and application process;\nan overview revision of the anatomy of upper and lower limb trauma and orthopaedic injury conservative management;\nthe clinical and knowledge and practical skills required to perform safe casting technique practiced in workshop conditions.\n\nLearning outcomes\nBy the end of the course\, the delegate will be able to: \n\nexplain how the knowledge and skills gained will develop their current competence;\napply anatomy and physiology in trauma and orthopaedic setting relating to the application of the correct immobilisation techniques;\nimplement and evaluate a prescription plan\, demonstrating the appropriate selection and application of materials and casting technique;\ndemonstrate in a workshop setting practical competence in the safe removal of a cast;\ninterpret the British Orthopaedic Association (BOA) Casting Guidelines specific to prescription and application making sound judgements and applying these to practice.\n\nAudience\nWhilst aimed at Surgical Trainees CT2 and above\, we welcome applications from experienced members of T&O MDTs. \nFees\n£225 \nDates and times\nDay One: Thursday 31 October 2024\n9:00am to 5:00pm \nDay Two: Friday 1 November 2024\n9:00am to 5:00pm \nVenue\nEldon Court\n2 Percy Street\nNewcastle upon Tyne\nNE1 7YE \nBooking\nTo book a place on this course go to Tickets at the bottom of the page. \nAt checkout you can make an online card payment or enter a coupon code to make alternative payment arrangements. \nAlternative payment arrangements include: \n\nrequesting an invoice (INVOICE)\,\nThe Newcastle upon Tyne Hospitals NHS Foundation Trust staff internal funding (NUTH) – you will need to complete a Trust study leave form.\n\nPlease see the Making payments & Coupons sections of the Help and FAQs.
URL:https://skillsacademy.newcastle-hospitals.nhs.uk/course/trauma-orthopaedic-surgical-trainee-casting-course-october-2024/
LOCATION:Eldon Court (ED) – Newcastle upon Tyne\, Eldon Court\, 2 Percy Street\, Newcastle Upon Tyne\, Tyne and Wear\, NE1 7YE\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://skillsacademy.newcastle-hospitals.nhs.uk/wp-content/uploads/2024/07/image00023-scaled-e1722239550468.jpeg
ORGANIZER;CN="Newcastle Hospitals Skills Academy":MAILTO:nuth.newcastlehospitalsskillsacademy@nhs.net
END:VEVENT
END:VCALENDAR